George Gunn

George Gunn is the founder and CEO of Stonehaven Consulting AG and a founding partner of CAH Capital GmbH. He has an extensive background in the healthcare industry, particularly in animal health. Gunn retired from Novartis AG in 2015, where he was a member of the Executive Committee since 2008. During his tenure at Novartis, he served in various leadership roles, including Head of Animal Health for North America and later Head of the Novartis Consumer Health Division. He also managed Corporate Social Responsibility for Novartis Corporation.134

Gunn's educational background includes veterinary medicine, having received an Honorary Degree of Doctor of Veterinary Medicine and Surgery from the University of Edinburgh in 2008. His career achievements have been recognized with several awards, including the Pharmacia Chairman’s Leadership Award in 2002 and the Novartis Chairman’s Excellence Award for Talent Development in 2007. Additionally, he received Lifetime Achievement Awards from the International Federation of Animal Health in 2015 and Animal Pharm in 2017.13

In December 2022, George Gunn became the Chairman of SC Group following the merger of Stonehaven Consulting and Cozmix, which created a global life sciences consultancy group.25